| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| 1. | Title: Overview of immunosuppression in liver transplantation
Author(s): Pillai AA, Levitsky J Source: WORLD JOURNAL OF GASTROENTEROLOGY Volume: 15 Issue: 34 Pages: 4225-4233 Published: SEP 14 2009 |
| 2. | Title: Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
Author(s): Jain A, Sharma R, Ryan C, et al. Source: LIVER TRANSPLANTATION Volume: 14 Issue: 2 Pages: 202-209 Published: FEB 2008 |
| 3. | Title: Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy
Author(s): Taylor AL, Watson CJE, Bradley JA Source: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY Volume: 56 Issue: 1 Pages: 23-46 Published: OCT 2005 |
| 4. | Title: Analysis of long-term outcomes of 3200 liver transplantations over two decades - A single-center experience
Author(s): Busuttil RW, Farmer DG, Yersiz H, et al. Source: ANNALS OF SURGERY Volume: 241 Issue: 6 Pages: 905-916 Published: JUN 2005 |
| 5. | Title: Visilizumab. Treatment of transplant rejection, - Treatment of IBD, antipsoriatic.
Author(s): Sorbera LA, Bayes M Source: DRUGS OF THE FUTURE Volume: 27 Issue: 5 Pages: 469-473 Published: MAY 2002 |
| 6. | Title: Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro
Author(s): Choi I, De Ines C, Kurschner T, et al. Source: EUROPEAN JOURNAL OF IMMUNOLOGY Volume: 31 Issue: 1 Pages: 94-106 Published: JAN 2001 |
| 7. | Title: Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
Author(s): Norman DJ, Vincenti F, de Mattos AM, et al. Source: TRANSPLANTATION Volume: 70 Issue: 12 Pages: 1707-1712 Published: DEC 27 2000 |
| 8. | Title: Liver transplantation: follow-up and complications.
Author(s): Vasseur B, Samuel D Source: GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE Volume: 23 Issue: 5BIS Pages: B66-B75 Published: JUN 1999 |
| 9. | Title: A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees
Author(s): Hsu DH, Shi JD, Homola M, et al. Source: TRANSPLANTATION Volume: 68 Issue: 4 Pages: 545-554 Published: AUG 27 1999 |
| 10. | Title: Use of antilymphocyte induction therapy in liver transplantation
Author(s): Wall WJ Source: LIVER TRANSPLANTATION AND SURGERY Volume: 5 Issue: 4 Pages: S64-S70 Supplement: Suppl. 1 Published: JUL 1999 |